Hemisphere Energy (HME) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
12 Sep, 2025Executive summary
Achieved Q2 2025 production of 3,826 boe/d (99% heavy oil), with revenue of $24.4 million ($70.06/boe).
Adjusted funds flow from operations (AFF) was $10.3 million ($29.47/boe), and free funds flow was $8.1 million ($0.07/share).
Distributed $2.4 million in base dividends and $2.9 million in special dividends; repurchased 1.3 million shares for $2.3 million.
Renewed $35 million credit facility and exited Q2 with $13.9 million in positive working capital.
Financial highlights
Q2 2025 petroleum and natural gas revenue was $24.4 million, down from $28.9 million in Q2 2024.
Operating field netback was $14.9 million ($42.77/boe), and operating netback was $14.0 million ($40.18/boe).
Cash flow from operating activities was $11.8 million, and net income was $7.1 million.
Capital expenditures totaled $2.2 million for the quarter.
Outlook and guidance
Drilling program scheduled to commence late Q3, including several development wells in Atlee Buffalo and at least one new well in Marsden.
Capital spending will be adjusted in response to oil market volatility.
Focus remains on balance sheet strength, shareholder returns, and potential acquisition opportunities.
Latest events from Hemisphere Energy
- Q3 2025 delivered strong cash flow, robust shareholder returns, and stable heavy oil production.HME
Q3 20255 Dec 2025 - Ultra-low decline oil assets and EOR drive high free cash flow and strong shareholder returns.HME
Corporate Presentation4 Jul 2025 - Q3 production and revenue rose sharply, with robust dividends and buybacks boosting shareholder returns.HME
Q3 202413 Jun 2025 - Record production and strong netbacks fueled higher earnings and robust shareholder returns.HME
Q2 202413 Jun 2025 - Record Q1 production and robust cash flow support increased dividends and share buybacks.HME
Q1 20256 Jun 2025 - Record production, rising cash flow, and strong shareholder returns highlight 2024 results.HME
Q4 20246 Jun 2025